您的位置: 首页 > 农业专利 > 详情页

通過CCR6阻斷CCL18信號作為纖維化疾病及癌症的治療選擇
专利权人:
UNIVERSITTSKLINIKUM FREIBURG
发明人:
ZISSEL, GERNOT,MLLER-QUERNHEIM, JOACHIM,PRASSE, ANTJE
申请号:
HK12100260.9
公开号:
HK1159525B
申请日:
2012.01.10
申请国别(地区):
HK
年份:
2015
代理人:
摘要:
The present invention relates to an isolated polypeptide capable of binding to and inhibiting the activity of the chemokine receptor CCR6 and to a method for identifying further inhibitors of CCR6 receptor activity. The present invention also relates to a method for detecting an interstitial lung disease or a cancer in a subject by determining the level of CCR6 gene expression in a sample from said subject and further provides pharmaceutical compositions comprising inhibitors of CCR6 receptor activity and/or expression for the treatment of said diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充